» Articles » PMID: 34508250

Autophagy in Metabolic Disease and Ageing

Overview
Specialty Endocrinology
Date 2021 Sep 11
PMID 34508250
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is an evolutionarily conserved, lysosome-dependent catabolic process whereby cytoplasmic components, including damaged organelles, protein aggregates and lipid droplets, are degraded and their components recycled. Autophagy has an essential role in maintaining cellular homeostasis in response to intracellular stress; however, the efficiency of autophagy declines with age and overnutrition can interfere with the autophagic process. Therefore, conditions such as sarcopenic obesity, insulin resistance and type 2 diabetes mellitus (T2DM) that are characterized by metabolic derangement and intracellular stresses (including oxidative stress, inflammation and endoplasmic reticulum stress) also involve the accumulation of damaged cellular components. These conditions are prevalent in ageing populations. For example, sarcopenia is an age-related loss of skeletal muscle mass and strength that is involved in the pathogenesis of both insulin resistance and T2DM, particularly in elderly people. Impairment of autophagy results in further aggravation of diabetes-related metabolic derangements in insulin target tissues, including the liver, skeletal muscle and adipose tissue, as well as in pancreatic β-cells. This Review summarizes the role of autophagy in the pathogenesis of metabolic diseases associated with or occurring in the context of ageing, including insulin resistance, T2DM and sarcopenic obesity, and describes its potential as a therapeutic target.

Citing Articles

Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.


Important regulatory role of mitophagy in diabetic microvascular complications.

Hu X, Lv J, Zhao Y, Li X, Qi W, Wang X J Transl Med. 2025; 23(1):269.

PMID: 40038741 PMC: 11877814. DOI: 10.1186/s12967-025-06307-7.


Functions and Therapeutic Potentials of Long Noncoding RNA in Skeletal Muscle Atrophy and Dystrophy.

Zhang Y, Wang T, Wang Z, Shi X, Jin J J Cachexia Sarcopenia Muscle. 2025; 16(2):e13747.

PMID: 40034097 PMC: 11876862. DOI: 10.1002/jcsm.13747.


Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy.

Chen J, He D, Yuan C, Li N, Shi B, Niu C J Orthop Translat. 2025; 51:68-81.

PMID: 39991457 PMC: 11847030. DOI: 10.1016/j.jot.2025.01.011.


Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis.

Wang Q, Li M, Chen C, Xu L, Fu Y, Xu J Theranostics. 2025; 15(6):2428-2450.

PMID: 39990211 PMC: 11840738. DOI: 10.7150/thno.104310.


References
1.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

2.
Kuk J, Saunders T, Davidson L, Ross R . Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009; 8(4):339-48. DOI: 10.1016/j.arr.2009.06.001. View

3.
Batsis J, Villareal D . Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018; 14(9):513-537. PMC: 6241236. DOI: 10.1038/s41574-018-0062-9. View

4.
Li N, Liu F, Yang P, Xiong F, Yu Q, Li J . Aging and stress induced β cell senescence and its implication in diabetes development. Aging (Albany NY). 2019; 11(21):9947-9959. PMC: 6874445. DOI: 10.18632/aging.102432. View

5.
Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View